Synopsis
Recognise papular inflammation around the mouth, nose and eyes, identify corticosteroid and product drivers, distinguish acne, rosacea and infection, and use low-burden withdrawal and anti-inflammatory treatment safely.
- Look for grouped 1–2 mm papules, papulovesicles or pustules around mouth, nose or eyes, often with dry sensitive skin and a narrow spared strip beside the lip vermilion.
- Absence of comedones helps separate periorificial dermatitis from acne; persistent diffuse centrofacial flushing and telangiectasia favour rosacea.
- Ask specifically about prescribed, borrowed and over-the-counter topical corticosteroids, transfer from hands, inhalers, nasal sprays, cosmetics and heavy facial products.
- Stop an unnecessary facial topical corticosteroid with an explained plan; warn that the eruption can flare temporarily after withdrawal and do not restart reflexively.
- Do not stop an essential inhaled or intranasal corticosteroid without controlling the airway indication; optimise technique, use a spacer when appropriate and clean exposed facial skin.
- Simplify skin care temporarily to lukewarm water or a gentle non-soap cleanser and a light tolerated product, then reintroduce necessities one at a time.
- Mild local disease can use a topical option off label; more extensive disease often responds to an off-label oral tetracycline for a defined four-to-six-week course.
- In children, pregnancy or breastfeeding, tetracycline treatment is unsuitable and alternative management should be selected with age- and pregnancy-specific expertise.
Key red flags
Eye pain, photophobia or reduced vision; honey-coloured crust with spreading infection; vesicles with ocular proximity; rapid facial swelling; fever; scarring; or a fixed photosensitive or granulomatous eruption requires urgent or specialist diagnostic review.
Eye pain, photophobia, reduced vision or corneal abnormality is not uncomplicated periocular skin disease and needs urgent ophthalmic assessment.
Investigation priorities
Find direct, transferred and aerosolised corticosteroid exposure and other potentially aggravating products.
Management branches
Typical periorificial lesions occur during direct or indirect facial corticosteroid exposure.
- Explain the association and possible temporary rebound, then stop an unnecessary facial corticosteroid; a supervised short taper with low-potency treatment is reserved for selected prolonged misuse rather than automatic continuation.
- Retain essential inhaled or intranasal treatment, coordinate with its prescriber, optimise device or spacer technique and wash or rinse exposed perioral skin after use.
- Temporarily simplify cosmetics, fragranced cleansers and heavy occlusive products, using a light tolerated moisturiser only when necessary, and review evolution over the next weeks.